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In this study we will collect and analyze scientific publications that review the 
correlation between anemia and breastfeeding, and anemia and maternal mental well-
being both prepartum and postpartum. The risks concerning iron deficiency anemia 
during pregnancy and postpartum are widely known; anemia increases the morbidity of 
both mother and child. Our aim is to review whether iron deficiency anemia affects the 
initiation and duration of breastfeeding and, on the other hand, whether it increases 
maternal depression and anxiety. 
 
According to our study, consensus whether anemia affects the initiation and duration of 
breastfeeding has not been reached. There are only a few studies of the association 
between postpartum anemia and duration of breastfeeding, and none of the association 
between anemia during pregnancy and duration of breastfeeding. Further research on 
the subject is needed. 
 
The association between anemia and mental well-being, on the other hand, has been 
studied widely in the past. The studies concern mostly the association of anemia and 
postpartum depression. The evidence suggests that especially postpartum anemia is a 
major risk factor for postpartum depression. 
 
We suggest that promotion of maternal health by means of treatment of iron deficiency 
anemia during pregnancy and postpartum by adequate iron supplementation could be 
one of the key factors in the prevention of maternal postpartum depression, anemia and 
possibly also cessation of breastfeeding. 
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Aim of the study 
 
In this study we will collect and analyze scientific publications that review the 
correlation between anemia and breastfeeding, and anemia and maternal mental well-
being. We will evaluate the effect of both prepartum and postpartum anemia on the 
subjects. Since mental well-being is hard to define and measure, we have outlined the 
mental well-being to include studies that view the association between anemia and 
depression or anxiety. 
 
  
1.1 Anemia 
 
In anemia, the number of red blood cells does not meet the body’s physiological needs1. 
Other way to define anemia is trough hemoglobin level; in anemia, the blood 
hemoglobin concentration is low
2,3
. Common symptoms of anemia include fatigue, 
dyspnea and dizziness. Depending on how low the hemoglobin level is and how fast it 
has gone down, the symptoms tend to be more severe.
4
 
 
Globally, iron deficiency is the most common cause behind anemia
1
. Other causes can 
be folate, vitamin B12 and vitamin A deficiency; inflammations; parasitic infections; and 
disorders affecting hemoglobin synthesis, red blood cell production or red blood cell 
survival
1
. In World Health Organization’s (WHO) report of the prevalence of anemia in 
2011, it was estimated that globally 38 % of pregnant women and 29 % of non-pregnant 
women in fertile age had anemia, affecting 32 million pregnant women and 496 million 
non-pregnant women altogether
2
.  
 
In Finland, the most common causes of anemia are iron deficiency and secondary 
anemia
5
. Secondary anemia, or anemia of chronic disease, is an inflammatory response 
to a chronic disease in which erythropoiesis attenuates and the utilization of iron 
decreases due to inflammatory transmitters and hepcidin.
6
  In WHO Global Database on 
Anaemia (2005), the prevalence of anemia in different populations in Finland varied 
between 3.4 and 59.0 % when anemia was considered hemoglobin level below 120 g/l. 
When only non-pregnant women were taken into consideration, the prevalence was 
from 3.4 % to 11 %. Among pregnant women, the prevalence was 10-19 % before 
giving birth and 41-59 % after birth.
7
 
 
According to WHO, for non-pregnant women, the normal hemoglobin level is 120 g/l or 
higher, and for men 130 g/l or higher
1
, but the diagnostic levels may vary in different 
countries; in Finland, the normal hemoglobin level for non-pregnant women is set at 
117 g/l and for men at 134 g/l
4,8
. For pregnant women, WHO recommends using 110 g/l 
or higher as a diagnostic level for anemia
1
; the same level is used in Finland
8
. The 
severity of anemia can be further assessed in three different diagnostic groups according 
to the level of hemoglobin: mild (100-109 g/l for pregnant women), moderate (70-99 
g/l) and severe (< 70 g/l)
1
. 
1.2 Anemia in pregnancy and postpartum 
 
In every pregnancy, the level of hemoglobin decreases due to hemodilution. In 
hemodilution, the volume of circulating blood increases 40-50 % to ensure blood flow 
to the uterus. At the same time, the erythropoiesis accelerates, but because the increase 
in the amount of plasma is greater than the increase in the amount of red blood cells, the 
blood gets diluted.
9-11
 Hemodilution might cause anemia. In pregnancy, anemic level of 
hemoglobin is considered to be 110 g/l or lower
1,8,9
. The hemodilution starts already in 
the first trimester, but the increase in volume is steepest at the second trimester, after 
which the rate of increase slows down in the third trimester
10
. 
 
Anemia during pregnancy has been seen to increase the risk for prematurity12-14, low 
birth weight of the infant14,15, cesarean delivery12,14, infant’s admission to a neonatal 
unit12, fetal intrauterine death16, and maternal death14,17. To prevent anemia during 
pregnancy and postpartum, WHO recommends a daily oral iron supplementation of 30-
60 mg of elemental iron. If side-effects prevent taking iron supplementation daily, 
intermittent oral iron supplementation with 120 mg of elemental iron once a week is 
recommended.18 In Finland, it is recommended by Finnish institute for health and 
welfare that if the hemoglobin level of the expectant mother is under 115 g/l after 12 
gestational weeks, she should start taking an iron supplementation of 50-100 mg of iron 
daily19. 
 
The prevalence of postpartum anemia is high worldwide; 50 % of the mothers who were 
anemic in the third trimester had also postpartum anemia, and 25 % of mothers who did 
not have anemia in the third trimester developed anemia postpartum
20-22
. For 
postpartum anemia, the main cause is anemia during pregnancy combined with heavy 
bleeding during and after childbirth
23,24
, with other risk factors being the lack of regular 
postpartum iron supplementation and young maternal age
24,25
. In addition to being one 
of the leading causes of postpartum anemia, heavy bleeding during and after childbirth 
remains the most common cause of pregnancy-related cause of death and morbidity, 
with uterine atony, trauma and prolonged second stage of labor increasing the risk
26-28
. 
There are multiple definitions of significant postpartum hemorrhage. American 
Congress of Obstetricians and Gynecologists define early postpartum hemorrhage as 
significant if the cumulative volume of lost blood is 1000 ml or higher, or if there are 
signs or symptoms of hypovolemia within 24 hours of giving birth
29. WHO’s definition 
of significant hemorrhage is 500 ml or more within 24 hours of giving birth.
27
 In 
Finland, the blood loss is considered normal if it is less than 500 ml after vaginal 
delivery and less than 1000 ml after cesarean section
30
. 
 
1.3 Breastfeeding 
 
The advantages of breastfeeding are widely known. For the infant, breastfeeding 
benefits the health and survival, enhances the intellectual and motor development, and 
reduces the risk for chronic diseases, while simultaneously increasing the health of the 
mother
31,32
. Breastfeeding has a positive effect on maternal mental well-being by 
inducing a calmer psychological state and by decreasing stress and anxiousness. These 
are believed to be mediated by oxytocin interaction with cortisol pathway.
33
 Interplay 
between oxytocin and other regulators of human lactation (e.g. estrogen, progesterone 
and prolactin) influences human behavior and mental well-being in terms of sexual 
behavior, maternal behavior, friendly social interactions, stress and anxiety alleviation 
and attenuation of nociception, learning and memory
34
. World Health Organization 
(WHO) recommends that mothers breastfeed infants exclusively until the age of six 
months. WHO also recommends that the breastfeeding continues up to the age of two 
years or beyond, whilst simultaneously nutritious complementary foods are 
administrated.
35
 
 
In Finland, 92 % of infants under the age of one month are breastfed, and 47 % of these 
infants exclusively. The amount of exclusively breastfed infants tends to decrease when 
the infant gets older; at the age of 5-6 months, only 9 % of infants are exclusively 
breastfed, while 57 % are partially breastfed and 34 % are not breastfed at all. Out of 
over 11 months old infants, 1 % is exclusively breastfed, 33 % partially breastfed and 
66 % not breastfed at all. The median point to stop breastfeeding for Finnish mothers is 
at 2.3 months, and the average at 3.1 months.
36
 
 
There are multiple factors that influence the initiation and continuity of breastfeeding. 
According to studies, women with higher level of education, marriage, stable financial 
status and attendance to prenatal classes are more likely to initiate breastfeeding, and 
women with higher level of education, older age, commitment to non-smoking and 
participation in a home visitor program are more likely to continue breastfeeding
37,38
. 
Postpartum fatigue is one of the main causes of ceasing to breastfeed
22,39
, and it can be 
associated not only with reduced amounts of sleep but also with low levels of ferritin 
and hemoglobin
40
. Self-reported insufficient milk and delayed onset of breastfeeding are 
interconnecting factors most commonly leading to cessation of breastfeeding
41
. Stress 
indicators including longer labor duration, maternal exhaustion, increased stress 
hormones and unscheduled cesarean section are associated not only with difficulties in 
breastfeeding
41
 but also with iron deficiency anemia during pregnancy
12
. Furthermore, 
since breastmilk has a low iron concentration and the concentration cannot be altered 
through maternal supplementation, restoration of mother’s iron status during pregnancy 
or even before seems to be important
42
. 
 
1.4 The effect of iron deficiency on fetus 
 
When considering the effect of iron deficiency on fetus, it has been proven that iron is 
essential for central nervous system development (myelination, neurotransmitter 
function, neuronal energy metabolism and dendritogenesis). Several studies have shown 
an association between iron deficiency anemia and iron depletion in infancy and poor 
cognitive and behavioral performance.43 Evolutionary conserved mechanisms of active 
iron transport from the mother to the fetus ensure normal neurodevelopment in mild or 
moderate maternal iron deficiency anemia, and the fetus is mostly protected from 
significant iron deficiency anemia in European settings. Accordingly, iron 
supplementation of pregnant women is not believed to improve infant’s iron status in 
Europe in general.44 However, in the developing countries with high frequency of 
malnutrition associated severe maternal iron deficiency anemia, iron supplementation 
seems to have beneficial effects on infant’s iron status45,46. To improve infant’s iron 
status, late cord clamping has been shown to be effective both in high and low income 
countries47,48. 
1.5 Mental well-being postpartum 
 
Most women are mentally more sensitive after giving birth, a period which is also 
known as “baby blues” or “postpartum blues”. This is considered a normal part of 
becoming a mother; up to 80 % of new mothers experience the symptoms. Postpartum 
blues usually goes by without other interventions than psychological support. 
Symptoms include crying, mood swings, headache, irritation, lack of appetite, and 
insomnia. The symptoms are usually worst at 3-5 days postpartum, but can last for 
several weeks. Though baby blues as a condition is considered harmless, it is important 
to remember that it increases the risk for postpartum depression.
49,50
 
 
Postpartum depression (PPD) is defined as depression that occurs after giving birth
51
. 
Usually, the symptoms appear within 3 months of delivery, but may occur up to 6 
months after giving birth
49,50
. As many as 10-20 % of mothers get PPD. Depressive 
symptoms prior to pregnancy and PPD in earlier pregnancies increase the risk. Other 
risk factors are antenatal depression, first pregnancy, marital problems, unmarried life, 
cesarean section, mental illnesses in the family, stress, negative experiences during 
pregnancy, lack of social support, and mother’s bipolar disorder. The symptoms of PPD 
include insomnia, joylessness, flightiness, feelings of inadequacy, and excessive 
worrying over the newborn.
49-51
 
 PPD results in a diminished ability to take care of the infant and endangers the normal 
development of a healthy maternal-infant bond, as well as increases the later morbidity 
to mental illnesses for the whole family. The infants of mothers who have PPD are also 
more likely to have delays in cognitive and language development. Therefore, it is 
important to evaluate maternal mental well-being.
49,51
 The use of screening tools for 
postpartum depression, such as Edinburgh Postnatal Depression Scale (EPDS), may 
help with early detection of the disease and reduce the adverse effects
50
. PPD can be 
treated the same way as any other depression: antidepressive medication, social support, 
and psychotherapy
49-51
. However, if medication is initiated, it is important to take into 
account the secretion of the chosen drug into breast milk
49
. 
 
Postpartum psychosis is a psychotic form of PPD. It is the least common mental illness 
occurring postpartum but also the most severe one; it is considered a psychiatric 
emergency and requires hospitalization. The symptoms usually start emerging 3-14 days 
after delivery and include restlessness, insomnia, agitation, mood swings, confusion, 
manic psychotic episodes and hallucinations. The mother is in danger of committing 
suicide as well as harming the baby.
49,50
 Postpartum psychosis can be treated with 
antipsychotics, psychotherapy, and sometimes electrotherapy
49,50
. Social support of both 
the mother and the family is important. Prognosis is good after the first episode, but 
psychosis tends to recur in later pregnancies.
49
 
  
2. Anemia and breastfeeding 
2.1 The effect of anemia during pregnancy on breastfeeding 
 
No studies of the association between prepartum anemia and the duration of 
breastfeeding could be found, though as stated earlier, prepartum anemia is a main 
factor in the development of postpartum anemia
23,24
. 
 
However, as is reviewed earlier, iron status of the infant is important when considering 
the development of central nervous system43. Mello-Neto et al (2013) have studied the 
effect of iron supplementation during pregnancy on the iron quantity of lactating human 
milk. They found in their study that in 45 % of breastmilk from an anemic mother the 
concentration of iron is low.52 However, others have shown that there is no correlation 
between the mother’s blood iron parameters and the concentration of iron in 
breastmilk53,54. These findings suggest that the concentration of iron in breastmilk is 
controlled by a mechanism that prioritizes the needs of the baby. 
 
Pérez-Escamilla et al (2019) questioned the WHO recommendation of exclusive 
breastfeeding of all infants for 6 months. They discovered that iron deficiency in 
infancy could be reduced by delayed cord clamping in all infants. However, for low 
birth weight infants who are born to mothers with iron deficiency anemia during 
pregnancy, it is recommended that iron supplementation is started at the age of 2-3 
months, since there is a risk of early infancy iron deficiency anemia and associated 
neurodevelopmental problems. In others, delayed cord clamping has been considered to 
be sufficient to ensure adequate iron storages in the early infancy.41 
2.2 The effect of postpartum anemia on breastfeeding 
 
Only a few studies have been made concerning the relationship between postpartum 
anemia and duration of breastfeeding. According to Rioux et al. (2006), postpartum 
anemia seems to be related to the duration of breastfeeding. In their study, they aimed to 
recruit retrospectively all the mothers who had given birth between April 23, 1998 and 
February 25, 1999 in the Dr. Georges-L. Dumont Regional Hospital in Moncton, 
Canada. The study had 76 subjects. They asked the mothers to visit the hospital when 
their baby was 9 months old to partake in a questionnaire and to determine blood 
hemoglobin level. The hemoglobin level after giving birth could be found in the records 
since it is one of the routine tests taken from every mother two days postpartum in 
Canada. They asked about breastfeeding in the questionnaire and considered the baby to 
be breastfed if it had received only breastmilk and possible complementary foods but no 
commercial formulas. 82.9 % of mothers initiated breastfeeding, but only 73.7 % 
breastfed for more than 7 days. The amount of breastfeeding mothers decreased over 
time; 68 % of mothers breastfed for over a month, while 43.4 % breastfed their infants 
for over 4 months. Only 22.4 % of mothers continued to breastfeed the recommended 6 
months, and at the 9 month check-in, only 9 % were still breastfeeding. In the study, 
they found that postpartum hemoglobin level of under 95 g/l was associated with earlier 
cessation of breastfeeding (p<0.02).
38
 
 
Henly et al (1995), on the other hand, studied the correlation between anemia and 
insufficient milk in first-time mothers. They studied 630 first-time mothers that had 
given birth in a private urban hospital in United States. Out of these mothers, 22 % were 
anemic. Otherwise the mothers did not vary much in the measured variables. They had 
their hemoglobin measured and completed a questionnaire on discharge and then got 
contacted by telephone at 1, 3, 6, 9 and 12 months after giving birth. After this, only 
those women who were still breastfeeding at 12 months were contacted every 3 months 
until the breastfeeding was ceased.  Anemic mothers reported both more problems with 
insufficient milk and earlier cessation of breastfeeding. Out of the anemic mothers, 19.7 
% reported insufficient milk syndrome, whilst out of the non-anemic mothers only 11.4 
% had the same problem (OR=1.7). The mothers with insufficient milk syndrome 
breastfed exclusively for 3.8 weeks on average. In comparison, mothers without the 
syndrome were exclusively breastfeeding for 10.5 weeks on average. They could see 
similar trending on the cessation of breastfeeding: the mothers with insufficient milk 
syndrome breastfed on average for 12.1 weeks and mothers without the syndrome for 
30.7 weeks, leading to a mean difference of 18.6 weeks between the study groups. They 
could not, however, find a correlation between anemia and the duration of 
breastfeeding: the anemic mothers were exclusively breastfeeding on average for 9.0 
weeks compared to the 9.8 weeks of the non-anemic mothers, and the average age of the 
infant on cessation of breastfeeding was 26.1 weeks on anemic women and 28.7 weeks 
on non-anemic. However, the study’s results suggest that since anemia affects the 
production of milk, which in turn leads to decreased duration of breastfeeding, anemia 
is one of the risk factors of earlier cessation of breastfeeding.
21
  
 
Some studies have shown that red blood cell transfusion is associated with decreased 
prevalence in initiation of breastfeeding in women who suffered from postpartum 
hemorrhage and were therefore anemic.
34,35 
Drayton et al. (2016) studied retrospectively 
whether blood transfusion has an effect on breastfeeding from the data on all the 
mothers giving birth 2007-2012 in New South Wales, Australia. Out of these mothers 
they selected those who had had mild postpartum hemorrhage (PPH). The number of 
participants after exclusions were 39 787. Of all the mothers in the study, 88 % were 
breastfeeding at discharge (82 % exclusively and 6 % partially). Out of mothers who 
had PPH but did not need red blood cell transfusion, 88 % were breastfeeding at 
discharge (81 % exclusively and 7 % partially). In the group of mothers who had PPH 
and received blood transfusion, 82 % were breastfeeding at discharge (70 % exclusively 
and 12 % partially). The study indicated that the mothers who suffered from PPH and 
received a blood transfusion were breastfeeding less than the other mothers.
35
 This 
could indicate that there is no correlation between anemia and the initiation of 
breastfeeding, since the mothers whose anemia was treated with blood transfusion were 
breastfeeding less than the ones who did not receive the transfusion. 
 
Chessman et al (2018) used the same data as Drayton et al (2016) from 2007-2010. 
Their study aimed to find out whether red blood cell transfusion had an impact on 
breastfeeding among women who had suffered PPH, but taking into account postpartum 
hemoglobin levels. 80 % of the mothers who received a blood transfusion were 
breastfeeding at discharge, compared to 87 % of the mothers who did not receive a 
blood transfusion. Altogether 1828 mothers received red blood cell transfusion and out 
of these mothers, 38 % had hemoglobin level of < 70 g/l pre-transfusion, whilst 43 % 
had a hemoglobin level of 70-90 g/l, and 19 % had a hemoglobin level of > 90 g/l. In 
the group of mothers with hemoglobin level of < 70 g/l, 78.6 % were breastfeeding at 
discharge. The mothers who had a hemoglobin level of 70-90 g/l had an 81.3 % rate of 
breastfeeding at discharge. Mothers with hemoglobin level of > 90 g/l were 
breastfeeding at the rate of 80.9 % at discharge. The median hemoglobin level post-
transfusion was > 90 g/l in each group. The researchers concluded that since the 
correction of severe persisting anemia did not affect positively on the rate of 
breastfeeding, severe persisting anemia did not have an effect on breastfeeding.
55
 
 
Researchers Year Country 
Anemia decreases the duration of 
breastfeeding 
      (yes/no) 
Henly et al 1995 USA yes 
Rioux et al 2006 Canada yes 
Drayton et al 2016 Australia no 
Chessman et 
al 2018 Australia no 
 
Table 1: The effect of anemia to the duration of breastfeeding according to studies. 
  
3. Anemia and mental well-being 
3.1 The effect of anemia during pregnancy on maternal mental well-being 
 
There are a lot of studies from all around the world that assess the association of 
prenatal anemia with maternal well-being. The results of these studies are not 
conclusive; there are, though, slightly more studies indicating that anemia during 
pregnancy does have an effect on maternal mental well-being and especially on the 
incidence of PPD. 
 
Goshtasebi et al (2013) studied the relationship between anemia during pregnancy and 
PPD in Iranian population. They recruited 281 non-anemic mothers who had no history 
of antidepressant-use or chronic illnesses in Sari, Iran. The hemoglobin level was 
measured at delivery and to evaluate PPD, they used EPDS 4-6 weeks after giving birth. 
They used EPDS score of 13 to diagnose PPD. The prevalence of postpartum 
depression was 5.5 % altogether. The results indicated that hemoglobin level of under 
110 g/l at delivery increases the risk for PPD (OR=4.64).
56
  
 
In Räisänen et al’s (2014) study, all singleton births in Finland between 2002 and 2010 
were studied to determine the risk factors behind depression during pregnancy, as well 
as the outcomes of major depression. They had altogether 511 938 study subjects, out of 
which 0.8 % had major depression during pregnancy. The data was gathered from 
national health registers. They divided women into groups depending on the diagnosis 
codes they had had before and during pregnancy. Anemia was defined as hemoglobin 
level under 100 g/l, whilst other suspected risk factors were either gathered from 
diagnosis codes the mothers had or were based on reports from antenatal care. The 
strongest association was with depression prior to pregnancy. Out of the mothers who 
had major depression during pregnancy but no history of depression, 3.5 % had anemia, 
and out of the mothers who had major depression during pregnancy and a history of 
depression, 2.8 % had anemia, compared to the 1.6 % of mothers with no depression 
diagnosis and 2.6 % of mothers with prior depression but no depression during 
pregnancy. Adjusted OR of depression and anemia was 1.49 in their study, which 
indicates that prepartum anemia is a risk factor of developing a depression during 
pregnancy.
57
 
 
Alharbi et al (2014) on the other hand wanted to see which obstetric and demographic 
variables increase the risk of getting PPD in Saudi population. They collected data from 
352 mothers who gave birth in King Khalid University Hospital or Riyadh Military 
Hospital from April 2013 to May 2013 by interviewing the mothers 8 to 12 weeks 
postpartum and using EPDS to evaluate depressive symptoms. EPDS score of 10 or 
higher was considered diagnostic for PPD. They measured hemoglobin level both 
during pregnancy and postpartum, and considered the hemoglobin level anemic if it was 
under 110 g/l. The prevalence of PPD was 32.2 % altogether. Out of the depressive 
mothers, 39.8 % had low hemoglobin levels postpartum (OR=1.70), and 40.5 % were 
anemic during pregnancy (OR=1.44). The findings suggest that both anemia during 
pregnancy and postpartum play a role in increasing the risk for PPD.
58
 
 
Yilmaz et al (2016) studied the relationship between anemia and depression during 
pregnancy. They wanted to know whether the severity of anemia in the last trimester 
had a correlation with depressive symptoms. They did a cross-sectional study where 
they recruited 450 pregnant women on their routine third trimester antenatal follow-up 
from September 2013 to January 2014 in Ankara, Turkey. They evaluated depression by 
using EPDS and determined a score of 13 points as diagnostic for depression. The 
subjects were divided into two groups according to their hemoglobin level: anemic 
group (Hb < 110 g/l) and non-anemic group (Hb ≥ 110 g/l). They discovered that the 
total EPDS score was significantly higher in the anemic group than it was in the non-
anemic group (p=0.000), indicating that there is a relationship between anemia and 
depression in the last trimester of pregnancy.
59
 
 
Xu et al (2018) studied all mothers who gave birth to their first child in New South 
Wales, Australia, between 2004 and 2008. After exclusions they had altogether 75 954 
study subjects. The study was population based cohort study, and the subjects were 
traced back for 3 years prepartum and 3 years postpartum. They used hospital admission 
records to identify the mothers who had both a diagnosis for anemia and a diagnosis for 
depressive disorder or mental and behavioral disorder associated with puerperium. In 
their study, the admission to hospital due to depression was higher in women with 
anemia than those without (OR=1.62). The prevalence of anemia was significantly 
higher during peripartum period than it was otherwise. The proportion of hospital 
admissions for depression increased during the first two years postpartum, and was at 
their lowest on the year before giving birth. This was considered to be due to the fact 
that in the year before giving birth, the mothers had more hospital admissions 
altogether. The absolute amount of hospital admissions for depression was, however, 
higher in the year before giving birth in women with anemia.
60
  
 
One study focused on anxiety during pregnancy instead of depressive symptoms. Kang 
et al (2016) studied the prevalence of antenatal anxiety and factors associated with it. 
They conducted a cross-sectional study in Changchun, China between January 2015 and 
March 2015. They had 467 participants who were all at least 38 weeks pregnant when 
recruited. To evaluate antenatal anxiety, they used Self-Rating Anxiety Scale (SAS) and 
the score of 50 or over as a diagnostic value for anxiety. Unfortunately, it is not clear 
what cutoff point was used to define anemia. The prevalence of antenatal anxiety was 
20.6 % altogether. They found multiple variables that had an association with antenatal 
anxiety, out of which anemia during pregnancy was one (OR=2.387).
61
 
 
There are also studies that found no evidence of the correlation between prepartum 
anemia and maternal depression. Armony-Sivan et al (2012) evaluated the association 
between pre- and postpartum maternal iron status with depressive symptoms in two 
Chinese samples; the pilot sample had 137 study subjects and the confirmatory sample 
567. They did an observational study by using data from ongoing longitudinal studies. 
The pilot sample’s data was collected from May 2008 to January 2011 and confirmatory 
sample’s from November 2009 to November 2011. They evaluated iron status by 
measuring hemoglobin, mean corpuscle volume (MCV), zinc protoporphyrin (ZPP), 
ferritin, transferrin receptors and transferrin receptors index at mid-pregnancy, late 
pregnancy and 3 days postpartum. The anemic value for hemoglobin was set at under 
110 g/l. EPDS score of 10 or higher was used to determine PPD, and the assessment 
was conducted at 6 weeks postpartum. In the pilot study, 23.4 % of mothers had PPD, 
and in the confirmatory sample 20.3 %. They found no difference in EPDS scores in 
anemic and non-anemic mothers in mid-pregnancy (p=0.16), late pregnancy (p=0.26) or 
postpartum (p=0.40), nor were there differences in iron statuses.
62
 
 
Maeda et al (2020) made a large study concerning the correlation of anemia in different 
stages of pregnancy and postpartum with postpartum depression. The study design was 
a prospective cohort study, and they collected data between May 2010 and November 
2013 in Tokyo, Japan. They had altogether 1128 study subjects. They measured 
hemoglobin on second (24-28 weeks of gestation) and third (35-36 weeks of gestation) 
trimester and once after childbirth (4-6 days postpartum). To evaluate depression, EPDS 
was used at 4 weeks postpartum. Hemoglobin level was considered anemic if it was 
under 105 g/l in the second trimester, under 110 g/l in the third trimester, or under 100 
g/l in the postpartum period. EPDS score of 9 or higher was considered diagnostic for 
PPD.  In this study, there was a significant correlation between postpartum anemia and 
postpartum depression. Similar correlation could not be found between anemia on 
second or third trimester and postpartum depression.
63
 
 
Researchers Year Country 
Prepartum anemia associated with mental 
well-being 
      (yes/no) 
Armony-Sivan 
et al 2012 China no 
Goshtasebi et al 2013 Iran yes 
Räisänen et al 2014 Finland yes 
Alharbi et al 2014 
Saudi 
Arabia yes 
Yilmaz et al 2016 Turkey yes 
Kang et al 2016 China yes 
Xu et al 2018 Australia yes 
Maeda et al 2020 Japan no 
Table 2: The effect of anemia during pregnancy on maternal mental well-being. 
 
Since the findings of the association between anemia and postpartum depression have 
been controversial in earlier studies, Azami et al (2019) did a of studies that were 
published of the subject until January 2018. They found a clear association between 
anemia and postpartum depression and according to their review, anemia during 
pregnancy increases the risk for PPD significantly.
64
 
3.2 The effect of postpartum anemia on maternal mental well-being 
 
The studies concerning the effect of postpartum anemia on maternal mental well-being 
are leaning more towards the evidence that anemia postpartum does have an effect on 
mental well-being. There are, however, also two studies that have found no association 
between the two
62,65
. 
 
Xu et al’s (2018) study from Australia is described in the previous chapter (3.1 The 
effect of anemia during pregnancy on mental wellbeing). Their study found a 
correlation between the hospital admissions for depression and anemia both pre- and 
postpartum.
60
 Alharbi et al (2014) on the other hand found a correlation of both pre- and 
postpartum anemia with PPD in Saudi population; said study is further described in the 
previous chapter
58
. Also Maeda et al’s (2020) study is described in detail in the previous 
chapter. They discovered an association between postpartum anemia and PPD 
(OR=1.63), but no association between prepartum anemia and PPD.
63
 
 Corwin et al (2003) studied the correlation between hemoglobin levels and postpartum 
depressive symptoms in Pennsylvania, USA. They recruited 37 healthy mothers from 
who they measured hemoglobin via finger-prick blood and evaluated depressive 
symptoms by using The Center for Epidemiological Studies – Depressive 
Symptomalogy Scale (CES-D). The mother was considered anemic if hemoglobin level 
was under 120 g/l. In CES-D, 11-15 points indicated mild depression and 16 points or 
over severe depression. All subjects were visited at their home at 900-1000 hours after 
discharge and on the 7
th
, 14
th
 and 28
th
 day postpartum. They found a correlation 
between anemic hemoglobin level on day 7 and depressive symptoms on day 28. No 
correlation could be found between hemoglobin levels on day 14 or 28 and depressive 
symptoms. The results suggest that early postpartum anemia is a risk factor for 
developing PPD.
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 It is important to take into consideration that finger-prick blood was 
used instead of venous blood to evaluate hemoglobin, which might cause error in 
results. 
 
Beard et al (2005) wanted to determine whether iron deficiency anemia has an effect on 
maternal cognitive and behavioral performance. They conducted a prospective, 
randomized, controlled intervention trial in Khayelitsha, South Africa, among 3 groups 
of mothers: non-anemic, anemic with daily iron supplementation (125 mg of FeSO4) 
and anemic with placebo. The total amount of study subjects was 81. The mothers were 
assessed at 10 weeks and 9 months postpartum. They defined iron deficiency anemia as 
follows: hemoglobin level of 90-115 g/l, and at least two of the following iron 
deficiency parameters: MCV <80 fl, transferrin saturation < 15 %, or serum ferritin < 12 
μg/l. They evaluated the mothers’ psychological state by using EPDS, the Raven’s 
Colored Progressive Matrices test and 2 Perceived Stress scales. At baseline, there was 
no difference between the groups in cognitive and behavioral variables. There was, 
however, a 25 % improvement in depression and stress scales in the group of mothers 
that were anemic and received iron supplementation at the 9 month evaluation point 
(p=0.05). They concluded that postpartum depression, stress and cognitive impairment 
may be related to iron deficiency anemia, and that the results suggest that iron therapy 
might reduce depression and stress in mothers with iron deficiency anemia.
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Albacar et al (2011) studied the association of iron status 48 hours after delivery with 
postpartum depression. The study design was a prospective cohort study. They studied 
depression-free women after giving birth in several general hospitals in Spain between 
December 2003 and October 2004. They had 729 study subjects, after excluding 
mothers with high C-reactive protein (CRP) and other diseases that are known to 
interfere with iron metabolism. They evaluated depressive symptoms 48 hours, 8 weeks 
and 32 weeks postpartum by using EPDS. The women with a score of 9 or higher at the 
8 or 32 weeks postpartum were identified as probably suffering from depression. To the 
women with scores lower than 9, a diagnostic interview was conducted to confirm the 
diagnosis of depression, or the lack of it. From every mother was taken a blood sample 
48 hours after delivery in order to measure the ferritin, transferrin, free iron and 
transferrin saturation, as well as CRP. 19.2 % of mothers got an EPDS score of 9 or 
higher at 48 hours postpartum, 12.4 % at 8 weeks postpartum, and 13.4 % at 32 weeks 
postpartum. 9 % of the mothers were diagnosed with major depression during the study. 
Out of the women who had postpartum depression, 38.5 % had iron depletion (ferritin < 
12 μg/l), whereas only 23.3 % of the non-depression group had iron depletion. The 
results of the study suggest that there is an association between low ferritin level 
postpartum and postpartum depression (p=0.001, OR = 2.91).
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Eckerdal et al (2016) studied the association between postpartum hemorrhage and 
postpartum depression, whilst taking into account postpartum anemia, delivery 
experience and psychiatric history. The study design was a nested cohort study. The 
study subjects came from two population based longitudinal studies conducted between 
May 2006 and November 2012 in Uppsala, Sweden. There were altogether 446 study 
subjects that were divided into two groups: those who had postpartum hemorrhage of 
over 1000 ml within 24 hours of giving birth (n=196), and those who had postpartum 
hemorrhage of under 650 ml (n=250). The depressive symptoms of the mother were 
evaluated at 6 weeks after delivery. They used EPDS score of 12 or higher to identify 
the study subjects with PPD. In addition to postpartum hemorrhage and postpartum 
depression, they evaluated multiple other factors, including anemia both during 
pregnancy and after delivery. They used hemoglobin of 110 g/l or under as a diagnostic 
level for anemia. They could not find an association between postpartum hemorrhage 
and postpartum depression. There was, however, a positive association between anemia 
at discharge and postpartum depression (p=0.014; OR = 2.29). A weaker yet not 
significant association could also be found between anemia during pregnancy and 
postpartum depression (p=0.057).
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There are, however, also studies that show no association between postpartum anemia 
and depression. Chandrasekaran et al (2018) aimed to determine whether postpartum 
anemia is an independent risk factor for PPD in women who had uncomplicated term 
cesarean section. They recruited 103 women in Canada and measured their hemoglobin 
and iron status 3-5 days and 6 weeks after delivery. The presence of PPD was evaluated 
24 hours after cesarean section, and then at 3 and 6 weeks after delivery. They, too, used 
EPDS to evaluate PPD and set the diagnostic score for PPD at 10 points or higher. 
Anemia was defined as hemoglobin level of under 110 g/l. 17 % of participants had a 
diagnostic score for PPD in EPDS. They found no evidence of the relationship between 
postpartum anemia and depression; there was no difference in hemoglobin or iron status 
in women with PPD compared to those without PPD (OR=-0.69). They concluded that 
anemia or poor iron status are not independent risk factors for PPD in women who have 
cesarean section.
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 Another study from China found no evidence of association between 
postpartum depression and pre- or postpartum anemia in two Chinese samples. The 
study from Armony-Sivan (2012) is described in detail in the previous chapter.
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Researchers Year Country 
Postpartum anemia associated with mental 
well-being 
      (yes/no) 
Corwin et al 2003 USA yes 
Beard et al 2005 
South 
Africa yes 
Albacar et al 2011 Spain yes 
Armony-Sivan 
et al 2012 China no 
Alharbi et al 2014 
Saudi 
Arabia yes 
Eckerdal et al 2016 Sweden yes 
Xu et al 2018 Australia yes 
Chandrasekara
n et al 2018 Canada no 
Maeda et al 2020 Japan yes 
Table 3: The effect of postpartum anemia on maternal mental well-being. 
 
Azami et al’s (2019) meta-analysis has been described in detail in the previous chapter. 
In their study, they also reviewed the association of postpartum anemia with PPD. They 
evaluated altogether 10 studies considering the association between postpartum anemia 
and PPD, and in all of them the prevalence of PPD was significantly higher in women 
with postpartum anemia than in women with no anemia.
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4. Conclusions 
 
Anemia is one of the major factors concerning the well-being of a mother postpartum. A 
consensus whether anemia affects the duration of breastfeeding has not been reached. 
There are only a few studies of the association between postpartum anemia and duration 
of breastfeeding, and none of the association between anemia during pregnancy and 
duration of breastfeeding. Further research on the subject is needed. 
 
On the other hand, the association between anemia and mental well-being has been 
studied widely. The studies concern mostly the association of anemia and postpartum 
depression. The evidence suggests that especially postpartum anemia is a major risk 
factor for postpartum depression. A recent study in which the association of anemia in 
different trimesters and postpartum with depression was assessed. It seemed that anemia 
during pregnancy is not a risk factor for postpartum depression but postpartum anemia 
is.
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Since breastfeeding, mother-child bonding and maternal mental well-being are strongly 
interconnected, we suggest that promotion of maternal health by means of treatment of 
iron deficiency anemia during pregnancy and postpartum by adequate iron 
supplementation could be one of the key factors in the prevention of maternal 
postpartum depression, anemia and cessation of breastfeeding. 
